Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Neutral Rating on Camtek (CAMT) as Competitive Risks Persist
-
Cantor Fitzgerald Reiterates Overweight Rating on Nova Measuring Instruments (NVMI)
-
Advanced Energy Industries (AEIS) Well Positioned Into Q2 Earnings and Beyond, Says Analyst
-
Cantor Fitzgerald Reiterates Overweight Rating on FormFactor (FORM) on Long-Term Potential
-
Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
-
Cantor Fitzgerald: MKS Instruments (MKSI) 'Remains Our Top Pick Within the SMID Cap Space'
-
Cantor Fitzgerald Starts Critical Metals (CRML) at Spec. Buy
-
H1 2026 Operations Update
-
Orchid Island Capital Announces Estimated Second Quarter 2026 Results and June 30, 2026 RMBS Portfolio Characteristics
-
Q32 Bio launches $200M stock offering to fund clinical trials
-
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
-
Samos Energy raises $230M in NYSE IPO for energy acquisitions
-
Samos Energy Acquisition Corporation Announces Closing of $230 Million Initial Public Offering
-
Merlin Labs (MRLN) Reiterated at Overweight by Cantor Fitzgerald on Defense Programs
-
Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald Amid U.K. Expansion
-
GitLab (GTLB) Reiterated at Neutral by Cantor Fitzgerald on Consumption Trends, Strategy
-
Regeneron Pharma (REGN) Reiterated at Overweight by Cantor Fitzgerald
-
Annexon Biosciences (ANNX) Reiterate at Overweight by Cantor Fitzgerald on Vonaprument
-
Immunocore Holdings (IMCR) Reiterated at Overweight by Cantor Fitzgerald
-
Beta Technologies (BETA) Reiterate at Overweight by Cantor Fitzgerald as EIPPP Announced
-
Archer Aviation (ACHR) Reiterated at Overweight by Cantor Fitzgerald on EIPP Order
-
Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald After USSF Mission
-
Goldman lawyer Ruemmler to be questioned by House panel on Epstein ties
-
Samos Energy prices IPO of 20M units at $10 each on NYSE
-
Samos Energy Acquisition Corporation Announces Pricing of Initial Public Offering
-
Opus Genetics (IRD) Reiterated at Overweight by Cantor Fitzgerald on Positive Update
-
Form 8-K Cantor Fitzgerald Income For: Jul 07
-
Willis Towers Watson (WTW) PT Raised to $344 at Cantor Fitzgerald on Better Q2 Setup
-
Ryan Specialty Group (RYAN) PT Raised to $34 at Cantor Fitzgerald as Shares Rally
-
RenaissanceRe Holdings (RNR) PT Raised to $354 at Cantor Fitzgerald on EPS Estimate Raise
-
Everest Group (EG) PT Raised to $390 at Cantor Fitzgerald on Likely 'Lighter Catastrophes'
-
Arch Capital (ACGL) PT Raised to $102 at Cantor Fitzgerald on Raised Estimates
-
W.R. Berkley (WRB) PT Raised to $74 at Cantor Fitzgerald on Stable Underlying Margins
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Chubb Corporation (CB) PT Raised to $337 at Cantor Fitzgerald: 'Remains Well-Positioned'
-
Travelers (TRV) PT Raised to $360 at Cantor Fitzgerald on Evading Margin Deterioration
-
Cantor Fitzgerald Starts HCI Group (HCI) at Overweight
-
Cantor Fitzgerald Starts Merlin Labs (MRLN) at Overweight
-
Cantor Fitzgerald Starts Velo3D (VELO) at Overweight
-
Cantor Fitzgerald Upgrades American International Group (AIG) to Overweight
-
Cantor Equity Partners I, Inc. and Bitcoin Standard Treasury Company Provide Update on Proposed Business Combination
-
ON Semiconductor (ON) Reiterated at Neutral by Cantor Fitzgerald: Setup Positive
-
NXP Semiconductors NV (NXPI) Reiterated at Overweight by Cantor Fitzgerald: 'Best Value Play'
-
Microchip Technology (MCHP) Reiterated at Overweight by Cantor Fitzgerald on Likely Beat, Raise
-
Vera Therapeutics (VERA) Reiterated at Overweight by Cantor Fitzgerald on Trutakna Approval
-
DigitalOcean (DOCN) Reiterated at Overweight by Cantor Fitzgerald on Q2 Pre-Announcement
-
MasTec (MTZ) Reiterated at Overweight by Cantor Fitzgerald as Acquisition Agreement Announced
-
Alumis (ALMS) Reiterated at Overweight by Cantor Fitzgerald Ahead of Phase 2b SLE Readout
-
Analog Devices (ADI) Reiterated at Overweight by Cantor Fitzgerald on Likely Upside
-
Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight

